+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Extracorporeal Membrane Oxygenation Therapy Market by Type (Venoarterial, Venovenous), Application (Cardiac, Extracorporeal Cardiopulmonary Resuscitation, Respiratory), Product, Patient Age, Hospital Type - Global Forecast 2025-2030- Product Image
Extracorporeal Membrane Oxygenation Therapy Market by Type (Venoarterial, Venovenous), Application (Cardiac, Extracorporeal Cardiopulmonary Resuscitation, Respiratory), Product, Patient Age, Hospital Type - Global Forecast 2025-2030- Product Image
New

Extracorporeal Membrane Oxygenation Therapy Market by Type (Venoarterial, Venovenous), Application (Cardiac, Extracorporeal Cardiopulmonary Resuscitation, Respiratory), Product, Patient Age, Hospital Type - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 181 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 6135740
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

An In-Depth Introduction to the Evolution and Clinical Imperatives of Extracorporeal Membrane Oxygenation Therapy in Modern Critical Care Settings

Extracorporeal membrane oxygenation (ECMO) therapy has evolved from its origins as an experimental life support technique into a cornerstone intervention for critically ill patients. Initially conceived to provide temporary cardiopulmonary support during surgical procedures, ECMO systems now underpin advanced treatment pathways for conditions ranging from severe respiratory distress to refractory cardiac failure. The advent of sophisticated pump designs, biocompatible membrane surfaces, and integrated monitoring systems has transformed clinical protocols, enabling safer and more effective deployment in intensive care settings.

Today, the integration of ECMO into multidisciplinary patient management frameworks underscores its importance as both a rescue therapy and a bridge to recovery or transplantation. Clinicians leverage ECMO to stabilize hemodynamics, ensure adequate oxygen delivery, and buy critical time for underlying pathologies to resolve or for definitive interventions to take effect. This introduction outlines key milestones in the technology’s progression and sets the stage for understanding current dynamics, emerging innovations, and strategic considerations that define the landscape of extracorporeal support in modern medicine.

Revolutionary Treatment Modalities and Technological Innovations Redefining Extracorporeal Membrane Oxygenation Therapy Protocols and Patient Management Strategies

The landscape of extracorporeal membrane oxygenation is undergoing transformative shifts fueled by both technological breakthroughs and evolving clinical paradigms. Miniaturization of pump and oxygenator components has enhanced portability, permitting mobile ECMO deployment in emergency scenarios and facilitating interfacility patient transfers. Simultaneously, artificial intelligence-driven hemodynamic monitoring tools provide real-time analytics, enabling care teams to fine-tune flow rates, detect early signs of hemolysis, and mitigate thrombotic risks.

In parallel, adaptive circuit designs and next-generation biocompatible coatings are reducing inflammatory responses and enhancing circuit longevity, which in turn lowers complication rates and supports longer-term use. These innovations dovetail with the emergence of specialized training programs and standardized protocols that optimize patient selection criteria, streamline cannulation procedures, and foster collaborative models between cardiothoracic surgeons, pulmonologists, and critical care specialists. As these developments converge, ECMO therapy is poised to deliver unprecedented clinical efficacy while improving resource utilization across healthcare ecosystems.

Assessing the Aggregate Impact of United States Tariffs Announced for 2025 on Supply Chains, Manufacturing Economics, and Distribution of ECMO Therapy Components

The introduction of new tariff schedules by the United States in 2025 has imparted a notable cumulative impact on the economics of extracorporeal membrane oxygenation therapy. Import duties on key components have led manufacturers to reconsider supply chain geographies, resulting in strategic shifts toward regionalized production hubs. Although some cost pressures have been absorbed through efficiency gains and supplier consolidation, the added financial burden has occasionally translated into elevated prices for end-users, with downstream effects on hospital budgeting and procurement cycles.

Importers have responded by negotiating long-term agreements to lock in favorable terms and by collaborating with regulatory authorities to streamline customs processes. Additionally, manufacturers have accelerated partnerships with contract research organizations and local assemblers to diversify their distribution networks. These adaptive strategies mitigate tariff-related headwinds and ensure continuity of supply, but they also underscore the delicate balance between policy environment, manufacturing agility, and the imperative to maintain broad patient access to critical life support technologies.

Unraveling Key Insights across Type, Application, Product, Patient Age, and Hospital Type to Illuminate the Multifaceted Segmentation of the ECMO Market

A nuanced understanding of segmentation sheds light on the multifaceted nature of the ECMO therapy domain. Based on type, systems are distinguished between venoarterial support, which offers both respiratory and circulatory assistance, and venovenous configurations that focus on gas exchange alone. When viewed through the lens of application, the technology spans cardiac pathologies, extracorporeal cardiopulmonary resuscitation for emergency stabilization, and primary respiratory indications where conventional ventilation proves insufficient.

Examining segmentation by product reveals an array of critical accessories, from cannula and pumps to oxygenators and tubing, each component playing a pivotal role in circuit integrity and patient safety. Patient age further refines the market landscape with adult cohorts, neonatal cases, and pediatric interventions demanding tailored cannulation strategies, flow settings, and biocompatible materials. Finally, hospital type delineates specialized environments such as cardiac care centers, tertiary hospitals, and pediatric and neonatal care institutions, the latter of which subdivides into neonatal care hospitals and dedicated pediatric facilities. This holistic segmentation framework illuminates the interplay between technology, clinical need, and care setting, offering stakeholders precise clarity for strategic planning.

Analyzing Regional Dynamics in the Americas, Europe, Middle East and Africa, and Asia-Pacific to Unearth Distinct Trends Shaping ECMO Therapy Adoption and Access

Regional analysis reveals divergent trends in the adoption and maturation of extracorporeal membrane oxygenation therapy. In the Americas, robust infrastructure and established critical care networks support widespread deployment, while ongoing investments in mobile ECMO units and specialized transport teams further enhance emergency response capabilities. Meanwhile, Europe, Middle East and Africa regions exhibit varied adoption rates tied to differences in regulatory frameworks, reimbursement policies, and healthcare budgets, driving targeted initiatives to expand critical care capacity and improve clinician training programs.

In the Asia-Pacific arena, rapid healthcare modernization and government-backed schemes are accelerating the uptake of advanced life support technologies. Emerging markets are increasingly partnering with global technology providers to localize manufacturing and training, thereby overcoming logistical barriers and lowering costs. Across all regions, collaborative research consortia and cross-border academic exchanges foster the dissemination of best practices, ensuring that advancements in ECMO therapy translate into tangible clinical improvements worldwide. This regional perspective underscores the importance of tailoring market entry strategies to local dynamics while leveraging global expertise.

Evaluating Prominent Industry Players Driving Innovation, Strategic Partnerships, and Product Portfolio Expansion in the Extracorporeal Membrane Oxygenation Arena

A cadre of companies is driving progress in extracorporeal membrane oxygenation through ongoing research, diversified product portfolios, and strategic partnerships. Industry leaders have broadened their offerings to include fully integrated systems, combining cutting-edge oxygenators with automated pump controls that simplify operation and enhance patient safety. Simultaneously, collaborative agreements with academic centers and biotech firms are yielding novel biocompatible coatings and sensor technologies that minimize blood trauma and enable predictive maintenance of ECMO circuits.

Some manufacturers are also entering into joint ventures to expand localized assembly operations and after-sales services, reducing lead times and ensuring rapid response to clinical needs. Moreover, select players have invested in training academies to certify multidisciplinary teams, bolstering procedural proficiency and reinforcing the clinical value proposition. These collective efforts reflect a competitive landscape driven by technological differentiation, regulatory compliance, and a commitment to elevating patient outcomes through continuous innovation.

Actionable Strategies for Healthcare Organizations and Stakeholders to Enhance ECMO Program Performance, Optimize Resource Allocation, and Drive Clinical Outcomes

Healthcare organizations seeking to harness the full potential of ECMO therapy should prioritize investments in multidisciplinary training and protocol standardization. Establishing dedicated ECMO teams that include surgeons, perfusionists, critical care nurses, and respiratory therapists promotes seamless coordination during initiation, maintenance, and weaning phases. In parallel, integrating advanced monitoring platforms and decision-support systems can sharpen real-time clinical insights, allowing teams to optimize flow parameters and swiftly address complications.

Operational excellence can be further enhanced by forging strategic partnerships with component suppliers to secure flexible supply agreements and technical support. This collaborative approach mitigates risk associated with sudden demand spikes and geoeconomic disruptions. Finally, continuous outcome tracking through robust data registries will yield actionable metrics on survival rates, complication incidences, and resource utilization. By adopting these recommendations, stakeholders can drive clinical efficacy, streamline resource allocation, and fortify their position in the competitive landscape of extracorporeal support.

Rigorous Research Methodology Detailing Data Sources, Analytical Frameworks, and Validation Techniques Underpinning the ECMO Therapy Market Analysis

This research synthesizes primary and secondary data sources to deliver a comprehensive analysis of the extracorporeal membrane oxygenation therapy landscape. Primary research involved structured interviews with key opinion leaders, including cardiothoracic surgeons, perfusionists, and healthcare administrators, complemented by insights from regulatory filings and clinical trial registries. Secondary sources encompassed peer-reviewed journals, industry white papers, and government documents, ensuring a robust evidentiary foundation.

Quantitative assessment employed a triangulation methodology, cross-validating findings through multiple independent data sets. Qualitative insights were distilled using thematic analysis to identify emerging trends, technology inflection points, and policy impacts. Rigorous validation steps, including expert panel reviews and gap analyses, guarantee the accuracy and relevance of the conclusions. This methodological rigor underpins the confidence stakeholders can place in the insights and strategic recommendations presented throughout this report.

Concluding Perspectives on the Future Trajectory of ECMO Therapy Emphasizing Emerging Opportunities, Potential Challenges, and Sustained Clinical Impact

As extracorporeal membrane oxygenation therapy continues its trajectory toward greater clinical sophistication and broader adoption, the convergence of innovation, policy shifts, and global collaboration will shape its future. Anticipated advancements in biocompatible materials and sensor integration promise to further reduce complications and enable extended support durations. At the same time, evolving regulatory landscapes and shifting reimbursement paradigms will influence investment decisions and access equity across regions.

Longitudinal data collection and outcome benchmarking will serve as critical levers for demonstrating value and securing institutional commitment. Furthermore, as healthcare systems grapple with rising demand for critical care capacity, mobile ECMO modalities and tele-monitoring networks may redefine traditional delivery models. In sum, the future of ECMO therapy lies in harmonizing technological progress with sustainable care frameworks to ensure that lifesaving support reaches patients in need around the globe.

Market Segmentation & Coverage

This research report categorizes to forecast the revenues and analyze trends in each of the following sub-segmentations:
  • Type
    • Venoarterial
    • Venovenous
  • Application
    • Cardiac
    • Extracorporeal Cardiopulmonary Resuscitation
    • Respiratory
  • Product
    • Accessories
    • Cannula
    • Oxygenator
    • Pump
    • Tubing
  • Patient Age
    • Adult
    • Neonatal
    • Pediatric
  • Hospital Type
    • Cardiac Care Centers
    • Pediatric And Neonatal Care Hospitals
      • Neonatal Care Hospitals
      • Pediatric Care Hospitals
    • Tertiary Care Hospitals
This research report categorizes to forecast the revenues and analyze trends in each of the following sub-regions:
  • Americas
    • United States
      • California
      • Texas
      • New York
      • Florida
      • Illinois
      • Pennsylvania
      • Ohio
    • Canada
    • Mexico
    • Brazil
    • Argentina
  • Europe, Middle East & Africa
    • United Kingdom
    • Germany
    • France
    • Russia
    • Italy
    • Spain
    • United Arab Emirates
    • Saudi Arabia
    • South Africa
    • Denmark
    • Netherlands
    • Qatar
    • Finland
    • Sweden
    • Nigeria
    • Egypt
    • Turkey
    • Israel
    • Norway
    • Poland
    • Switzerland
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • Indonesia
    • Thailand
    • Philippines
    • Malaysia
    • Singapore
    • Vietnam
    • Taiwan
This research report delves into recent significant developments and analyzes trends in each of the following companies:
  • Getinge AB
  • Medtronic plc
  • LivaNova PLC
  • Terumo Corporation
  • Fresenius Medical Care AG & Co. KGaA
  • Nikkiso Co., Ltd.
  • ICU Medical, Inc.
  • Levitronix LLC
  • Nipro Corporation
  • Hemovent GmbH

This product will be delivered within 1-3 business days.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Increasing adoption of portable and ambulatory ECMO systems enabling patient mobility
5.2. Integration of AI-driven predictive analytics to optimize ECMO patient management and outcomes
5.3. Rising use of hybrid ECMO configurations for combined cardiac and respiratory support in critical care
5.4. Development of biocompatible ECMO circuits to reduce inflammatory response and thrombosis risk
5.5. Emergence of extracorporeal CO2 removal platforms as adjunctive therapy in ARDS management
5.6. Growing investments in decentralized ECMO training programs to expand treatment accessibility
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Extracorporeal Membrane Oxygenation Therapy Market, by Type
8.1. Introduction
8.2. Venoarterial
8.3. Venovenous
9. Extracorporeal Membrane Oxygenation Therapy Market, by Application
9.1. Introduction
9.2. Cardiac
9.3. Extracorporeal Cardiopulmonary Resuscitation
9.4. Respiratory
10. Extracorporeal Membrane Oxygenation Therapy Market, by Product
10.1. Introduction
10.2. Accessories
10.3. Cannula
10.4. Oxygenator
10.5. Pump
10.6. Tubing
11. Extracorporeal Membrane Oxygenation Therapy Market, by Patient Age
11.1. Introduction
11.2. Adult
11.3. Neonatal
11.4. Pediatric
12. Extracorporeal Membrane Oxygenation Therapy Market, by Hospital Type
12.1. Introduction
12.2. Cardiac Care Centers
12.3. Pediatric And Neonatal Care Hospitals
12.3.1. Neonatal Care Hospitals
12.3.2. Pediatric Care Hospitals
12.4. Tertiary Care Hospitals
13. Americas Extracorporeal Membrane Oxygenation Therapy Market
13.1. Introduction
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. Argentina
14. Europe, Middle East & Africa Extracorporeal Membrane Oxygenation Therapy Market
14.1. Introduction
14.2. United Kingdom
14.3. Germany
14.4. France
14.5. Russia
14.6. Italy
14.7. Spain
14.8. United Arab Emirates
14.9. Saudi Arabia
14.10. South Africa
14.11. Denmark
14.12. Netherlands
14.13. Qatar
14.14. Finland
14.15. Sweden
14.16. Nigeria
14.17. Egypt
14.18. Turkey
14.19. Israel
14.20. Norway
14.21. Poland
14.22. Switzerland
15. Asia-Pacific Extracorporeal Membrane Oxygenation Therapy Market
15.1. Introduction
15.2. China
15.3. India
15.4. Japan
15.5. Australia
15.6. South Korea
15.7. Indonesia
15.8. Thailand
15.9. Philippines
15.10. Malaysia
15.11. Singapore
15.12. Vietnam
15.13. Taiwan
16. Competitive Landscape
16.1. Market Share Analysis, 2024
16.2. FPNV Positioning Matrix, 2024
16.3. Competitive Analysis
16.3.1. Getinge AB
16.3.2. Medtronic plc
16.3.3. LivaNova PLC
16.3.4. Terumo Corporation
16.3.5. Fresenius Medical Care AG & Co. KGaA
16.3.6. Nikkiso Co., Ltd.
16.3.7. ICU Medical, Inc.
16.3.8. Levitronix LLC
16.3.9. Nipro Corporation
16.3.10. Hemovent GmbH
17. ResearchAI18. ResearchStatistics19. ResearchContacts20. ResearchArticles21. Appendix
List of Figures
FIGURE 1. EXTRACORPOREAL MEMBRANE OXYGENATION THERAPY MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION THERAPY MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION THERAPY MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION THERAPY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION THERAPY MARKET SIZE, BY TYPE, 2024 VS 2030 (%)
FIGURE 6. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION THERAPY MARKET SIZE, BY TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION THERAPY MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 8. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION THERAPY MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION THERAPY MARKET SIZE, BY PRODUCT, 2024 VS 2030 (%)
FIGURE 10. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION THERAPY MARKET SIZE, BY PRODUCT, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION THERAPY MARKET SIZE, BY PATIENT AGE, 2024 VS 2030 (%)
FIGURE 12. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION THERAPY MARKET SIZE, BY PATIENT AGE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION THERAPY MARKET SIZE, BY HOSPITAL TYPE, 2024 VS 2030 (%)
FIGURE 14. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION THERAPY MARKET SIZE, BY HOSPITAL TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS EXTRACORPOREAL MEMBRANE OXYGENATION THERAPY MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 16. AMERICAS EXTRACORPOREAL MEMBRANE OXYGENATION THERAPY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES EXTRACORPOREAL MEMBRANE OXYGENATION THERAPY MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 18. UNITED STATES EXTRACORPOREAL MEMBRANE OXYGENATION THERAPY MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA EXTRACORPOREAL MEMBRANE OXYGENATION THERAPY MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA EXTRACORPOREAL MEMBRANE OXYGENATION THERAPY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. ASIA-PACIFIC EXTRACORPOREAL MEMBRANE OXYGENATION THERAPY MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. ASIA-PACIFIC EXTRACORPOREAL MEMBRANE OXYGENATION THERAPY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. EXTRACORPOREAL MEMBRANE OXYGENATION THERAPY MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 24. EXTRACORPOREAL MEMBRANE OXYGENATION THERAPY MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 25. EXTRACORPOREAL MEMBRANE OXYGENATION THERAPY MARKET: RESEARCHAI
FIGURE 26. EXTRACORPOREAL MEMBRANE OXYGENATION THERAPY MARKET: RESEARCHSTATISTICS
FIGURE 27. EXTRACORPOREAL MEMBRANE OXYGENATION THERAPY MARKET: RESEARCHCONTACTS
FIGURE 28. EXTRACORPOREAL MEMBRANE OXYGENATION THERAPY MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. EXTRACORPOREAL MEMBRANE OXYGENATION THERAPY MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION THERAPY MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION THERAPY MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION THERAPY MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION THERAPY MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION THERAPY MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION THERAPY MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION THERAPY MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION THERAPY MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION THERAPY MARKET SIZE, BY VENOARTERIAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION THERAPY MARKET SIZE, BY VENOARTERIAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION THERAPY MARKET SIZE, BY VENOVENOUS, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION THERAPY MARKET SIZE, BY VENOVENOUS, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION THERAPY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION THERAPY MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION THERAPY MARKET SIZE, BY CARDIAC, BY REGION, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION THERAPY MARKET SIZE, BY CARDIAC, BY REGION, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION THERAPY MARKET SIZE, BY EXTRACORPOREAL CARDIOPULMONARY RESUSCITATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION THERAPY MARKET SIZE, BY EXTRACORPOREAL CARDIOPULMONARY RESUSCITATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION THERAPY MARKET SIZE, BY RESPIRATORY, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION THERAPY MARKET SIZE, BY RESPIRATORY, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION THERAPY MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION THERAPY MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION THERAPY MARKET SIZE, BY ACCESSORIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION THERAPY MARKET SIZE, BY ACCESSORIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION THERAPY MARKET SIZE, BY CANNULA, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION THERAPY MARKET SIZE, BY CANNULA, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION THERAPY MARKET SIZE, BY OXYGENATOR, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION THERAPY MARKET SIZE, BY OXYGENATOR, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION THERAPY MARKET SIZE, BY PUMP, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION THERAPY MARKET SIZE, BY PUMP, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION THERAPY MARKET SIZE, BY TUBING, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION THERAPY MARKET SIZE, BY TUBING, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION THERAPY MARKET SIZE, BY PATIENT AGE, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION THERAPY MARKET SIZE, BY PATIENT AGE, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION THERAPY MARKET SIZE, BY ADULT, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION THERAPY MARKET SIZE, BY ADULT, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION THERAPY MARKET SIZE, BY NEONATAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION THERAPY MARKET SIZE, BY NEONATAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION THERAPY MARKET SIZE, BY PEDIATRIC, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION THERAPY MARKET SIZE, BY PEDIATRIC, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION THERAPY MARKET SIZE, BY HOSPITAL TYPE, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION THERAPY MARKET SIZE, BY HOSPITAL TYPE, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION THERAPY MARKET SIZE, BY CARDIAC CARE CENTERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION THERAPY MARKET SIZE, BY CARDIAC CARE CENTERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION THERAPY MARKET SIZE, BY PEDIATRIC AND NEONATAL CARE HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION THERAPY MARKET SIZE, BY PEDIATRIC AND NEONATAL CARE HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION THERAPY MARKET SIZE, BY NEONATAL CARE HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION THERAPY MARKET SIZE, BY NEONATAL CARE HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION THERAPY MARKET SIZE, BY PEDIATRIC CARE HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION THERAPY MARKET SIZE, BY PEDIATRIC CARE HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION THERAPY MARKET SIZE, BY PEDIATRIC AND NEONATAL CARE HOSPITALS, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION THERAPY MARKET SIZE, BY PEDIATRIC AND NEONATAL CARE HOSPITALS, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION THERAPY MARKET SIZE, BY TERTIARY CARE HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION THERAPY MARKET SIZE, BY TERTIARY CARE HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 57. AMERICAS EXTRACORPOREAL MEMBRANE OXYGENATION THERAPY MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 58. AMERICAS EXTRACORPOREAL MEMBRANE OXYGENATION THERAPY MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 59. AMERICAS EXTRACORPOREAL MEMBRANE OXYGENATION THERAPY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 60. AMERICAS EXTRACORPOREAL MEMBRANE OXYGENATION THERAPY MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 61. AMERICAS EXTRACORPOREAL MEMBRANE OXYGENATION THERAPY MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 62. AMERICAS EXTRACORPOREAL MEMBRANE OXYGENATION THERAPY MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 63. AMERICAS EXTRACORPOREAL MEMBRANE OXYGENATION THERAPY MARKET SIZE, BY PATIENT AGE, 2018-2024 (USD MILLION)
TABLE 64. AMERICAS EXTRACORPOREAL MEMBRANE OXYGENATION THERAPY MARKET SIZE, BY PATIENT AGE, 2025-2030 (USD MILLION)
TABLE 65. AMERICAS EXTRACORPOREAL MEMBRANE OXYGENATION THERAPY MARKET SIZE, BY HOSPITAL TYPE, 2018-2024 (USD MILLION)
TABLE 66. AMERICAS EXTRACORPOREAL MEMBRANE OXYGENATION THERAPY MARKET SIZE, BY HOSPITAL TYPE, 2025-2030 (USD MILLION)
TABLE 67. AMERICAS EXTRACORPOREAL MEMBRANE OXYGENATION THERAPY MARKET SIZE, BY PEDIATRIC AND NEONATAL CARE HOSPITALS, 2018-2024 (USD MILLION)
TABLE 68. AMERICAS EXTRACORPOREAL MEMBRANE OXYGENATION THERAPY MARKET SIZE, BY PEDIATRIC AND NEONATAL CARE HOSPITALS, 2025-2030 (USD MILLION)
TABLE 69. AMERICAS EXTRACORPOREAL MEMBRANE OXYGENATION THERAPY MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 70. AMERICAS EXTRACORPOREAL MEMBRANE OXYGENATION THERAPY MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 71. UNITED STATES EXTRACORPOREAL MEMBRANE OXYGENATION THERAPY MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 72. UNITED STATES EXTRACORPOREAL MEMBRANE OXYGENATION THERAPY MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 73. UNITED STATES EXTRACORPOREAL MEMBRANE OXYGENATION THERAPY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 74. UNITED STATES EXTRACORPOREAL MEMBRANE OXYGENATION THERAPY MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 75. UNITED STATES EXTRACORPOREAL MEMBRANE OXYGENATION THERAPY MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 76. UNITED STATES EXTRACORPOREAL MEMBRANE OXYGENATION THERAPY MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 77. UNITED STATES EXTRACORPOREAL MEMBRANE OXYGENATION THERAPY MARKET SIZE, BY PATIENT AGE, 2018-2024 (USD MILLION)
TABLE 78. UNITED STATES EXTRACORPOREAL MEMBRANE OXYGENATION THERAPY MARKET SIZE, BY PATIENT AGE, 2025-2030 (USD MILLION)
TABLE 79. UNITED STATES EXTRACORPOREAL MEMBRANE OXYGENATION THERAPY MARKET SIZE, BY HOSPITAL TYPE, 2018-2024 (USD MILLION)
TABLE 80. UNITED STATES EXTRACORPOREAL MEMBRANE OXYGENATION THERAPY MARKET SIZE, BY HOSPITAL TYPE, 2025-2030 (USD MILLION)
TABLE 81. UNITED STATES EXTRACORPOREAL MEMBRANE OXYGENATION THERAPY MARKET SIZE, BY PEDIATRIC AND NEONATAL CARE HOSPITALS, 2018-2024 (USD MILLION)
TABLE 82. UNITED STATES EXTRACORPOREAL MEMBRANE OXYGENATION THERAPY MARKET SIZE, BY PEDIATRIC AND NEONATAL CARE HOSPITALS, 2025-2030 (USD MILLION)
TABLE 83. UNITED STATES EXTRACORPOREAL MEMBRANE OXYGENATION THERAPY MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 84. UNITED STATES EXTRACORPOREAL MEMBRANE OXYGENATION THERAPY MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 85. CANADA EXTRACORPOREAL MEMBRANE OXYGENATION THERAPY MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 86. CANADA EXTRACORPOREAL MEMBRANE OXYGENATION THERAPY MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 87. CANADA EXTRACORPOREAL MEMBRANE OXYGENATION THERAPY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 88. CANADA EXTRACORPOREAL MEMBRANE OXYGENATION THERAPY MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 89. CANADA EXTRACORPOREAL MEMBRANE OXYGENATION THERAPY MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 90. CANADA EXTRACORPOREAL MEMBRANE OXYGENATION THERAPY MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 91. CANADA EXTRACORPOREAL MEMBRANE OXYGENATION THERAPY MARKET SIZE, BY PATIENT AGE, 2018-2024 (USD MILLION)
TABLE 92. CANADA EXTRACORPOREAL MEMBRANE OXYGENATION THERAPY MARKET SIZE, BY PATIENT AGE, 2025-2030 (USD MILLION)
TABLE 93. CANADA EXTRACORPOREAL MEMBRANE OXYGENATION THERAPY MARKET SIZE, BY HOSPITAL TYPE, 2018-2024 (USD MILLION)
TABLE 94. CANADA EXTRACORPOREAL MEMBRANE OXYGENATION THERAPY MARKET SIZE, BY HOSPITAL TYPE, 2025-2030 (USD MILLION)
TABLE 95. CANADA EXTRACORPOREAL MEMBRANE OXYGENATION THERAPY MARKET SIZE, BY PEDIATRIC AND NEONATAL CARE HOSPITALS, 2018-2024 (USD MILLION)
TABLE 96. CANADA EXTRACORPOREAL MEMBRANE OXYGENATION THERAPY MARKET SIZE, BY PEDIATRIC AND NEONATAL CARE HOSPITALS, 2025-2030 (USD MILLION)
TABLE 97. MEXICO EXTRACORPOREAL MEMBRANE OXYGENATION THERAPY MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 98. MEXICO EXTRACORPOREAL MEMBRANE OXYGENATION THERAPY MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 99. MEXICO EXTRACORPOREAL MEMBRANE OXYGENATION THERAPY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 100. MEXICO EXTRACORPOREAL MEMBRANE OXYGENATION THERAPY MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 101. MEXICO EXTRACORPOREAL MEMBRANE OXYGENATION THERAPY MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 102. MEXICO EXTRACORPOREAL MEMBRANE OXYGENATION THERAPY MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 103. MEXICO EXTRACORPOREAL MEMBRANE OXYGENATION THERAPY MARKET SIZE, BY PATIENT AGE, 2018-2024 (USD MILLION)
TABLE 104. MEXICO EXTRACORPOREAL MEMBRANE OXYGENATION THERAPY MARKET SIZE, BY PATIENT AGE, 2025-2030 (USD MILLION)
TABLE 105. MEXICO EXTRACORPOREAL MEMBRANE OXYGENATION THERAPY MARKET SIZE, BY HOSPITAL TYPE, 2018-2024 (USD MILLION)
TABLE 106. MEXICO EXTRACORPOREAL MEMBRANE OXYGENATION THERAPY MARKET SIZE, BY HOSPITAL TYPE, 2025-2030 (USD MILLION)
TABLE 107. MEXICO EXTRACORPOREAL MEMBRANE OXYGENATION THERAPY MARKET SIZE, BY PEDIATRIC AND NEONATAL CARE HOSPITALS, 2018-2024 (USD MILLION)
TABLE 108. MEXICO EXTRACORPOREAL MEMBRANE OXYGENATION THERAPY MARKET SIZE, BY PEDIATRIC AND NEONATAL CARE HOSPITALS, 2025-2030 (USD MILLION)
TABLE 109. BRAZIL EXTRACORPOREAL MEMBRANE OXYGENATION THERAPY MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 110. BRAZIL EXTRACORPOREAL MEMBRANE OXYGENATION THERAPY MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 111. BRAZIL EXTRACORPOREAL MEMBRANE OXYGENATION THERAPY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 112. BRAZIL EXTRACORPOREAL MEMBRANE OXYGENATION THERAPY MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 113. BRAZIL EXTRACORPOREAL MEMBRANE OXYGENATION THERAPY MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 114. BRAZIL EXTRACORPOREAL MEMBRANE OXYGENATION THERAPY MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 115. BRAZIL EXTRACORPOREAL MEMBRANE OXYGENATION THERAPY MARKET SIZE, BY PATIENT AGE, 2018-2024 (USD MILLION)
TABLE 116. BRAZIL EXTRACORPOREAL MEMBRANE OXYGENATION THERAPY MARKET SIZE, BY PATIENT AGE, 2025-2030 (USD MILLION)
TABLE 117. BRAZIL EXTRACORPOREAL MEMBRANE OXYGENATION THERAPY MARKET SIZE, BY HOSPITAL TYPE, 2018-2024 (USD MILLION)
TABLE 118. BRAZIL EXTRACORPOREAL MEMBRANE OXYGENATION THERAPY MARKET SIZE, BY HOSPITAL TYPE, 2025-2030 (USD MILLION)
TABLE 119. BRAZIL EXTRACORPOREAL MEMBRANE OXYGENATION THERAPY MARKET SIZE, BY PEDIATRIC AND NEONATAL CARE HOSPITALS, 2018-2024 (USD MILLION)
TABLE 120. BRAZIL EXTRACORPOREAL MEMBRANE OXYGENATION THERAPY MARKET SIZE, BY PEDIATRIC AND NEONATAL CARE HOSPITALS, 2025-2030 (USD MILLION)
TABLE 121. ARGENTINA EXTRACORPOREAL MEMBRANE OXYGENATION THERAPY MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 122. ARGENTINA EXTRACORPOREAL MEMBRANE OXYGENATION THERAPY MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 123. ARGENTINA EXTRACORPOREAL MEMBRANE OXYGENATION THERAPY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 124. ARGENTINA EXTRACORPOREAL MEMBRANE OXYGENATION THERAPY MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 125. ARGENTINA EXTRACORPOREAL MEMBRANE OXYGENATION THERAPY MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 126. ARGENTINA EXTRACORPOREAL MEMBRANE OXYGENATION THERAPY MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 127. ARGENTINA EXTRACORPOREAL MEMBRANE OXYGENATION THERAPY MARKET SIZE, BY PATIENT AGE, 2018-2024 (USD MILLION)
TABLE 128. ARGENTINA EXTRACORPOREAL MEMBRANE OXYGENATION THERAPY MARKET SIZE, BY PATIENT AGE, 2025-2030 (USD MILLION)
TABLE 129. ARGENTINA EXTRACORPOREAL MEMBRANE OXYGENATION THERAPY MARKET SIZE, BY HOSPITAL TYPE, 2018-2024 (USD MILLION)
TABLE 130. ARGENTINA EXTRACORPOREAL MEMBRANE OXYGENATION THERAPY MARKET SIZE, BY HOSPITAL TYPE, 2025-2030 (USD MILLION)
TABLE 131. ARGENTINA EXTRACORPOREAL MEMBRANE OXYGENATION THERAPY MARKET SIZE, BY PEDIATRIC AND NEONATAL CARE HOSPITALS, 2018-2024 (USD MILLION)
TABLE 132. ARGENTINA EXTRACORPOREAL MEMBRANE OXYGENATION THERAPY MARKET SIZE, BY PEDIATRIC AND NEONATAL CARE HOSPITALS, 2025-2030 (USD MILLION)
TABLE 133. EUROPE, MIDDLE EAST & AFRICA EXTRACORPOREAL MEMBRANE OXYGENATION THERAPY MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 134. EUROPE, MIDDLE EAST & AFRICA EXTRACORPOREAL MEMBRANE OXYGENATION THERAPY MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 135. EUROPE, MIDDLE EAST & AFRICA EXTRACORPOREAL MEMBRANE OXYGENATION THERAPY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 136. EUROPE, MIDDLE EAST & AFRICA EXTRACORPOREAL MEMBRANE OXYGENATION THERAPY MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 137. EUROPE, MIDDLE EAST & AFRICA EXTRACORPOREAL MEMBRANE OXYGENATION THERAPY MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 138. EUROPE, MIDDLE EAST & AFRICA EXTRACORPOREAL MEMBRANE OXYGENATION THERAPY MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 139. EUROPE, MIDDLE EAST & AFRICA EXTRACORPOREAL MEMBRANE OXYGENATION THERAPY MARKET SIZE, BY PATIENT AGE, 2018-2024 (USD MILLION)
TABLE 140. EUROPE, MIDDLE EAST & AFRICA EXTRACORPOREAL MEMBRANE OXYGENATION THERAPY MARKET SIZE, BY PATIENT AGE, 2025-2030 (USD MILLION)
TABLE 141. EUROPE, MIDDLE EAST & AFRICA EXTRACORPOREAL MEMBRANE OXYGENATION THERAPY MARKET SIZE, BY HOSPITAL TYPE, 2018-2024 (USD MILLION)
TABLE 142. EUROPE, MIDDLE EAST & AFRICA EXTRACORPOREAL MEMBRANE OXYGENATION THERAPY MARKET SIZE, BY HOSPITAL TYPE, 2025-2030 (USD MILLION)
TABLE 143. EUROPE, MIDDLE EAST & AFRICA EXTRACORPOREAL MEMBRANE OXYGENATION THERAPY MARKET SIZE, BY PEDIATRIC AND NEONATAL CARE HOSPITALS, 2018-2024 (USD MILLION)
TABLE 144. EUROPE, MIDDLE EAST & AFRICA EXTRACORPOREAL MEMBRANE OXYGENATION THERAPY MARKET SIZE, BY PEDIATRIC AND NEONATAL CARE HOSPITALS, 2025-2030 (USD MILLION)
TABLE 145. EUROPE, MIDDLE EAST & AFRICA EXTRACORPOREAL MEMBRANE OXYGENATION THERAPY MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 146. EUROPE, MIDDLE EAST & AFRICA EXTRACORPOREAL MEMBRANE OXYGENATION THERAPY MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 147. UNITED KINGDOM EXTRACORPOREAL MEMBRANE OXYGENATION THERAPY MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 148. UNITED KINGDOM EXTRACORPOREAL MEMBRANE OXYGENATION THERAPY MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 149. UNITED KINGDOM EXTRACORPOREAL MEMBRANE OXYGENATION THERAPY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 150. UNITED KINGDOM EXTRACORPOREAL MEMBRANE OXYGENATION THERAPY MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 151. UNITED KINGDOM EXTRACORPOREAL MEMBRANE OXYGENATION THERAPY MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 152. UNITED KINGDOM EXTRACORPOREAL MEMBRANE OXYGENATION THERAPY MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 153. UNITED KINGDOM EXTRACORPOREAL MEMBRANE OXYGENATION THERAPY MARKET SIZE, BY PATIENT AGE, 2018-2024 (USD MILLION)
TABLE 154. UNITED KINGDOM EXTRACORPOREAL MEMBRANE OXYGENATION THERAPY MARKET SIZE, BY PATIENT AGE, 2025-2030 (USD MILLION)
TABLE 155. UNITED KINGDOM EXTRACORPOREAL MEMBRANE OXYGENATION THERAPY MARKET SIZE, BY HOSPITAL TYPE, 2018-2024 (USD MILLION)
TABLE 156. UNITED KINGDOM EXTRACORPOREAL MEMBRANE OXYGENATION THERAPY MARKET SIZE, BY HOSPITAL TYPE, 2025-2030 (USD MILLION)
TABLE 157. UNITED KINGDOM EXTRACORPOREAL MEMBRANE OXYGENATION THERAPY MARKET SIZE, BY PEDIATRIC AND NEONATAL CARE HOSPITALS, 2018-2024 (USD MILLION)
TABLE 158. UNITED KINGDOM EXTRACORPOREAL MEMBRANE OXYGENATION THERAPY MARKET SIZE, BY PEDIATRIC AND NEONATAL CARE HOSPITALS, 2025-2030 (USD MILLION)
TABLE 159. GERMANY EXTRACORPOREAL MEMBRANE OXYGENATION THERAPY MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 160. GERMANY EXTRACORPOREAL MEMBRANE OXYGENATION THERAPY MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 161. GERMANY EXTRACORPOREAL MEMBRANE OXYGENATION THERAPY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 162. GERMANY EXTRACORPOREAL MEMBRANE OXYGENATION THERAPY MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 163. GERMANY EXTRACORPOREAL MEMBRANE OXYGENATION THERAPY MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 164. GERMANY EXTRACORPOREAL MEMBRANE OXYGENATION THERAPY MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 165. GERMANY EXTRACORPOREAL MEMBRANE OXYGENATION THERAPY MARKET SIZE, BY PATIENT AGE, 2018-2024 (USD MILLION)
TABLE 166. GERMANY EXTRACORPOREAL MEMBRANE OXYGENATION THERAPY MARKET SIZE, BY PATIENT AGE, 2025-2030 (USD MILLION)
TABLE 167. GERMANY EXTRACORPOREAL MEMBRANE OXYGENATION THERAPY MARKET SIZE, BY HOSPITAL TYPE, 2018-2024 (USD MILLION)
TABLE 168. GERMANY EXTRACORPOREAL MEMBRANE OXYGENATION THERAPY MARKET SIZE, BY HOSPITAL TYPE, 2025-2030 (USD MILLION)
TABLE 169. GERMANY EXTRACORPOREAL MEMBRANE OXYGENATION THERAPY MARKET SIZE, BY PEDIATRIC AND NEONATAL CARE HOSPITALS, 2018-2024 (USD MILLION)
TABLE 170. GERMANY EXTRACORPOREAL MEMBRANE OXYGENATION THERAPY MARKET SIZE, BY PEDIATRIC AND NEONATAL CARE HOSPITALS, 2025-2030 (USD MILLION)
TABLE 171. FRANCE EXTRACORPOREAL MEMBRANE OXYGENATION THERAPY MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 172. FRANCE EXTRACORPOREAL MEMBRANE OXYGENATION THERAPY MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 173. FRANCE EXTRACORPOREAL MEMBRANE OXYGENATION THERAPY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 174. FRANCE EXTRACORPOREAL MEMBRANE OXYGENATION THERAPY MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 175. FRANCE EXTRACORPOREAL MEMBRANE OXYGENATION THERAPY MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 176. FRANCE EXTRACORPOREAL MEMBRANE OXYGENATION THERAPY MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 177. FRANCE EXTRACORPOREAL MEMBRANE OXYGENATION THERAPY MARKET SIZE, BY PATIENT AGE, 2018-2024 (USD MILLION)
TABLE 178. FRANCE EXTRACORPOREAL MEMBRANE OXYGENATION THERAPY MARKET SIZE, BY PATIENT AGE, 2025-2030 (USD MILLION)
TABLE 179. FRANCE EXTRACORPOREAL MEMBRANE OXYGENATION THERAPY MARKET SIZE, BY HOSPITAL TYPE, 2018-2024 (USD MILLION)
TABLE 180. FRANCE EXTRACORPOREAL MEMBRANE OXYGENATION THERAPY MARKET SIZE, BY HOSPITAL TYPE, 2025-2030 (USD MILLION)
TABLE 181. FRANCE EXTRACORPOREAL MEMBRANE OXYGENATION THERAPY MARKET SIZE, BY PEDIATRIC AND NEONATAL CARE HOSPITALS, 2018-2024 (USD MILLION)
TABLE 182. FRANCE EXTRACORPOREAL MEMBRANE OXYGENATION THERAPY MARKET SIZE, BY PEDIATRIC AND NEONATAL CARE HOSPITALS, 2025-2030 (USD MILLION)
TABLE 183. RUSSIA EXTRACORPOREAL MEMBRANE OXYGENATION THERAPY MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 184. RUSSIA EXTRACORPOREAL MEMBRANE OXYGENATION THERAPY MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 185. RUSSIA EXTRACORPOREAL MEMBRANE OXYGENATION THERAPY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 186. RUSSIA EXTRACORPOREAL MEMBRANE OXYGENATION THERAPY MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 187. RUSSIA EXTRACORPOREAL MEMBRANE OXYGENATION THERAPY MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 188. RUSSIA EXTRACORPOREAL MEMBRANE OXYGENATION THERAPY MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 189. RUSSIA EXTRACORPOREAL MEMBRANE OXYGENATION THERAPY MARKET SIZE, BY PATIENT AGE, 2018-2024 (USD MILLION)
TABLE 190. RUSSIA EXTRACORPOREAL MEMBRANE OXYGENATION THERAPY MARKET SIZE, BY PATIENT AGE, 2025-2030 (USD MILLION)
TABLE 191. RUSSIA EXTRACORPOREAL MEMBRANE OXYGENATION THERAPY MARKET SIZE, BY HOSPITAL TYPE, 2018-2024 (USD MILLION)
TABLE 192. RUSSIA EXTRACORPOREAL MEMBRANE OXYGENATION THERAPY MARKET SIZE, BY HOSPITAL TYPE, 2025-2030 (USD MILLION)
TABLE 193. RUSSIA EXTRACORPOREAL MEMBRANE OXYGENATION THERAPY MARKET SIZE, BY PEDIATRIC AND NEONATAL CARE HOSPITALS, 2018-2024 (USD MILLION)
TABLE 194. RUSSIA EXTRACORPOREAL MEMBRANE OXYGENATION THERAPY MARKET SIZE, BY PEDIATRIC AND NEONATAL CARE HOSPITALS, 2025-2030 (USD MILLION)
TABLE 195. ITALY EXTRACORPOREAL MEMBRANE OXYGENATION THERAPY MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 196. ITALY EXTRACORPOREAL MEMBRANE OXYGENATION THERAPY MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 197. ITALY EXTRACORPOREAL MEMBRANE OXYGENATION THERAPY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 198. ITALY EXTRACORPOREAL MEMBRANE OXYGENATION THERAPY MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 199. ITALY EXTRACORPOREAL MEMBRANE OXYGENATION THERAPY MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 200. ITALY EXTRACORPOREAL MEMBRANE OXYGENATION THERAPY MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 201. ITALY EXTRACORPOREAL MEMBRANE OXYGENATION THERAPY MARKET SIZE, BY PATIENT AGE, 2018-2024 (USD MILLION)
TABLE 202. ITALY EXTRACORPOREAL MEMBRANE OXYGENATION THERAPY MARKET SIZE, BY PATIENT AGE, 2025-2030 (USD MILLION)
TABLE 203. ITALY EXTRACORPOREAL MEMBRANE OXYGENATION THERAPY MARKET SIZE, BY HOSPITAL TYPE, 2018-2024 (USD MILLION)
TABLE 204. ITALY EXTRACORPOREAL MEMBRANE OXYGENATION THERAPY MARKET SIZE, BY HOSPITAL TYPE, 2025-2030 (USD MILLION)
TABLE 205. ITALY EXTRACORPOREAL MEMBRANE OXYGENATION THERAPY MARKET SIZE, BY PEDIATRIC AND NEONATAL CARE HOSPITALS, 2018-2024 (USD MILLION)
TABLE 206. ITALY EXTRACORPOREAL MEMBRANE OXYGENATION THERAPY MARKET SIZE, BY PEDIATRIC AND NEONATAL CARE HOSPITALS, 2025-2030 (USD MILLION)
TABLE 207. SPAIN EXTRACORPOREAL MEMBRANE OXYGENATION THERAPY MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 208. SPAIN EXTRACORPOREAL MEMBRANE OXYGENATION THERAPY MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 209. SPAIN EXTRACORPOREAL MEMBRANE OXYGENATION THERAPY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 210. SPAIN EXTRACORPOREAL MEMBRANE OXYGENATION THERAPY MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 211. SPAIN EXTRACORPOREAL MEMBRANE OXYGENATION THERAPY MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 212. SPAIN EXTRACORPOREAL MEMBRANE OXYGENATION THERAPY MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 213. SPAIN EXTRACORPOREAL MEMBRANE OXYGENATION THERAPY MARKET SIZE, BY PATIENT AGE, 2018-2024 (USD MILLION)
TABLE 214. SPAIN EXTRACORPOREAL MEMBRANE OXYGENATION THERAPY MARKET SIZE, BY PATIENT AGE, 2025-2030 (USD MILLION)
TABLE 215. SPAIN EXTRACORPOREAL MEMBRANE OXYGENATION THERAPY MARKET SIZE, BY HOSPITAL TYPE, 2018-2024 (USD MILLION)
TABLE 216. SPAIN EXTRACORPOREAL MEMBRANE OXYGENATION THERAPY MARKET SIZE, BY HOSPITAL TYPE, 2025-2030 (USD MILLION)
TABLE 217. SPAIN EXTRACORPOREAL MEMBRANE OXYGENATION THERAPY MARKET SIZE, BY PEDIATRIC AND NEONATAL CARE HOSPITALS, 2018-2024 (USD MILLION)
TABLE 218. SPAIN EXTRACORPOREAL MEMBRANE OXYGENATION THERAPY MARKET SIZE, BY PEDIATRIC AND NEONATAL CARE HOSPITALS, 2025-2030 (USD MILLION)
TABLE 219. UNITED ARAB EMIRATES EXTRACORPOREAL MEMBRANE OXYGENATION THERAPY MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 220. UNITED ARAB EMIRATES EXTRACORPOREAL MEMBRANE OXYGENATION THERAPY MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 221. UNITED ARAB EMIRATES EXTRACORPOREAL MEMBRANE OXYGENATION THERAPY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 222. UNITED ARAB EMIRATES EXTRACORPOREAL MEMBRANE OXYGENATION THERAPY MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 223. UNITED ARAB EMIRATES EXTRACORPOREAL MEMBRANE OXYGENATION THERAPY MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 224. UNITED ARAB EMIRATES EXTRACORPOREAL MEMBRANE OXYGENATION THERAPY MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 225. UNITED ARAB EMIRATES EXTRACORPOREAL MEMBRANE OXYGENATION THERAPY MARKET SIZE, BY PATIENT AGE, 2018-2024 (USD MILLION)
TABLE 226. UNITED ARAB EMIRATES EXTRACORPOREAL MEMBRANE OXYGENATION THERAPY MARKET SIZE, BY PATIENT AGE, 2025-2030 (USD MILLION)
TABLE 227. UNITED ARAB EMIRATES EXTRACORPOREAL MEMBRANE OXYGENATION THERAPY MARKET SIZE, BY HOSPITAL TYPE, 2018-2024 (USD MILLION)
TABLE 228. UNITED ARAB EMIRATES EXTRACORPOREAL MEMBRANE OXYGENATION THERAPY MARKET SIZE, BY HOSPITAL TYPE, 2025-2030 (USD MILLION)
TABLE 229. UNITED ARAB EMIRATES EXTRACORPOREAL MEMBRANE OXYGENATION THERAPY MARKET SIZE, BY PEDIATRIC AND NEONATAL CARE HOSPITALS, 2018-2024 (USD MILLION)
TABLE 230. UNITED ARAB EMIRATES EXTRACORPOREAL MEMBRANE OXYGENATION THERAPY MARKET SIZE, BY PEDIATRIC AND NEONATAL CARE HOSPITALS, 2025-2030 (USD MILLION)
TABLE 231. SAUDI ARABIA EXTRACORPOREAL MEMBRANE OXYGENATION THERAPY MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 232. SAUDI ARABIA EXTRACORPOREAL MEMBRANE OXYGENATION THERAPY MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 233. SAUDI ARABIA EXTRACORPOREAL MEMBRANE OXYGENATION THERAPY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 234. SAUDI ARABIA EXTRACORPOREAL MEMBRANE OXYGENATION THERAPY MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 235. SAUDI ARABIA EXTRACORPOREAL MEMBRANE OXYGENATION THERAPY MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 236. SAUDI ARABIA EXTRACORPOREAL MEMBRANE OXYGENATION THERAPY MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 237. SAUDI ARABIA EXTRACORPOREAL MEMBRANE OXYGENATION THERAPY MARKET SIZE, BY PATIENT AGE, 2018-2024 (USD MILLION)
TABLE 238. SAUDI ARABIA EXTRACORPOREAL MEMBRANE OXYGENATION THERAPY MARKET SIZE, BY PATIENT AGE, 2025-2030 (USD MILLION)
TABLE 239. SAUDI ARABIA EXTRACORPOREAL MEMBRANE OXYGENATION THERAPY MARKET SIZE, BY HOSPITAL TYPE, 2018-2024 (USD MILLION)
TABLE 240. SAUDI ARABIA EXTRACORPOREAL MEMBRANE OXYGENATION THERAPY MARKET SIZE, BY HOSPITAL TYPE, 2025-2030 (USD MILLION)
TABLE 241. SAUDI ARABIA EXTRACORPOREAL MEMBRANE OXYGENATION THERAPY MARKET SIZE, BY PEDIATRIC AND NEONATAL CARE HOSPITALS, 2018-2024 (USD MILLION)
TABLE 242. SAUDI ARABIA EXTRACORPOREAL MEMBRANE OXYGENATION THERAPY MARKET SIZE, BY PEDIATRIC AND NEONATAL CARE HOSPITALS, 2025-2030 (USD MILLION)
TABLE 243. SOUTH AFRICA EXTRACORPOREAL MEMBRANE OXYGENATION THERAPY MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 244. SOUTH AFRICA EXTRACORPOREAL MEMBRANE OXYGENATION THERAPY MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 245. SOUTH AFRICA EXTRACORPOREAL MEMBRANE OXYGENATION THERAPY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 246. SOUTH AFRICA EXTRACORPOREAL MEMBRANE OXYGENATION THERAPY MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 247. SOUTH AFRICA EXTRACORPOREAL MEMBRANE OXYGENATION THERAPY MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 248. SOUTH AFRICA EXTRACORPOREAL MEMBRANE OXYGENATION THERAPY MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 249. SOUTH AFRICA EXTRACORPOREAL MEMBRANE OXYGENATION THERAPY MARKET SIZE, BY PATIENT AGE, 2018-2024 (USD MILLION)
TABLE 250. SOUTH AFRICA EXTRACORPOREAL MEMBRANE OXYGENATION THERAPY MARKET SIZE, BY PATIENT AGE, 2025-2030 (USD MILLION)
TABLE 251. SOUTH AFRICA EXTRACORPOREAL MEMBRANE OXYGENATION THERAPY MARKET SIZE, BY HOSPITAL TYPE, 2018-2024 (USD MILLION)
TABLE 252. SOUTH AFRICA EXTRACORPOREAL MEMBRANE OXYGENATION THERAPY MARKET SIZE, BY HOSPITAL TYPE, 2025-2030 (USD MILLION)
TABLE 253. SOUTH AFRICA EXTRACORPOREAL MEMBRANE OXYGENATION THERAPY MARKET SIZE, BY PEDIATRIC AND NEONATAL CARE HOSPITALS, 2018-2024 (USD MILLION)
TABLE 254. SOUTH AFRICA EXTRACORPOREAL MEMBRANE OXYGENATION THERAPY MARKET SIZE, BY PEDIATRIC AND NEONATAL CARE HOSPITALS, 2025-2030 (USD MILLION)
TABLE 255. DENMARK EXTRACORPOREAL MEMBRANE OXYGENATION THERAPY MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 256. DENMARK EXTRACORPOREAL MEMBRANE OXYGENATION THERAPY MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 257. DENMARK EXTRACORPOREAL MEMBRANE OXYGENATION THERAPY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 258. DENMARK EXTRACORPOREAL MEMBRANE OXYGENATION THERAPY MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 259. DENMARK EXTRACORPOREAL MEMBRANE OXYGENATION THERAPY MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 260. DENMARK EXTRACORPOREAL MEMBRANE OXYGENATION THERAPY MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 261. DENMARK EXTRACORPOREAL MEMBRANE OXYGENATION THERAPY MARKET SIZE, BY PATIENT AGE, 2018-2024 (USD MILLION)
TABLE 262. DENMARK EXTRACORPOREAL MEMBRANE OXYGENATION THERAPY MARKET SIZE, BY PATIENT AGE, 2025-2030 (USD MILLION)
TABLE 263. DENMARK EXTRACORPOREAL MEMBRANE OXYGENATION THERAPY MARKET SIZE, BY HOSPITAL TYPE, 2018-2024 (USD MILLION)
TABLE 264. DENMARK EXTRACORPOREAL MEMBRANE OXYGENATION THERAPY MARKET SIZE, BY HOSPITAL TYPE, 2025-2030 (USD MILLION)
TABLE 265. DENMARK EXTRACORPOREAL MEMBRANE OXYGENATION THERAPY MARKET SIZE, BY PEDIATRIC AND NEONATAL CARE HOSPITALS, 2018-2024 (USD MILLION)
TABLE 266. DENMARK EXTRACORPOREAL MEMBRANE OXYGENATION THERAPY MARKET SIZE, BY PEDIATRIC AND NEONATAL CARE HOSPITALS, 2025-2030 (USD MILLION)
TABLE 267. NETHERLANDS EXTRACORPOREAL MEMBRANE OXYGENATION THERAPY MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 268. NETHERLANDS EXTRACORPOREAL MEMBRANE OXYGENATION THERAPY MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 269. NETHERLANDS EXTRACORPOREAL MEMBRANE OXYGENATION THERAPY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 270. NETHERLANDS EXTRACORPOREAL MEMBRANE OXYGENATION THERAPY MAR

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Extracorporeal Membrane Oxygenation Therapy Market report include:
  • Getinge AB
  • Medtronic plc
  • LivaNova PLC
  • Terumo Corporation
  • Fresenius Medical Care AG & Co. KGaA
  • Nikkiso Co., Ltd.
  • ICU Medical, Inc.
  • Levitronix LLC
  • Nipro Corporation
  • Hemovent GmbH

Related Topics

Related Reports

Extracorporeal Membrane Oxygenation Machine Market by Device Type (Veno Arterial, Veno Venous), Application (Cardiac Support, Extracorporeal Cardiopulmonary Resuscitation, Respiratory Support), End User, Technology Type - Global Forecast 2025-2030 - Product Image

Extracorporeal Membrane Oxygenation Machine Market by Device Type (Veno Arterial, Veno Venous), Application (Cardiac Support, Extracorporeal Cardiopulmonary Resuscitation, Respiratory Support), End User, Technology Type - Global Forecast 2025-2030

  • Report
  • 190 Pages
  • Global
From
Extracorporeal Membrane Oxygenation Cannula Market Size, Share & Trends Analysis Report By Type (Veno-arterial, Arterio-venous), By Patient Type (Adult, Pediatric), By Application, By End-use, By Region, And Segment Forecasts, 2024 - 2030 - Product Image

Extracorporeal Membrane Oxygenation Cannula Market Size, Share & Trends Analysis Report By Type (Veno-arterial, Arterio-venous), By Patient Type (Adult, Pediatric), By Application, By End-use, By Region, And Segment Forecasts, 2024 - 2030

  • Report
  • 140 Pages
  • Global
From
Extracorporeal Membrane Oxygenation (ECMO) Machine - Global Strategic Business Report - Product Image

Extracorporeal Membrane Oxygenation (ECMO) Machine - Global Strategic Business Report

  • Report
  • 294 Pages
  • Global
From
Extracorporeal Membrane Oxygenation Cannula - Global Strategic Business Report - Product Image

Extracorporeal Membrane Oxygenation Cannula - Global Strategic Business Report

  • Report
  • 463 Pages
  • Global
From
Extracorporeal Membrane Oxygenation (ECMO) Devices - Market Insights, Competitive Landscape, and Market Forecast - 2030 - Product Image

Extracorporeal Membrane Oxygenation (ECMO) Devices - Market Insights, Competitive Landscape, and Market Forecast - 2030

  • Report
  • 150 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.